Seeking Alpha

Akorn (AKRX -0.4%) has reportedly received FDA approval for its generic version of of Allergan's...

Akorn (AKRX -0.4%) has reportedly received FDA approval for its generic version of of Allergan's (AGN) Alocril, a prescription eye drop for itchy allergy eyes.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)